Workflow
ALK(002940)
icon
Search documents
昂利康(002940.SZ):西格列汀二甲双胍缓释片完成药品注册
智通财经网· 2025-07-31 09:09
Group 1 - The company, Anglikang (002940.SZ), has received the drug registration certificate for Sitagliptin Metformin Extended-Release Tablets from the National Medical Products Administration [1] - Sitagliptin Metformin Extended-Release Tablets are a compound preparation suitable for adult patients with type 2 diabetes who are currently receiving combined treatment with Sitagliptin and Metformin Extended-Release Tablets [1]
A股龙虎榜丨昂利康涨停,六家机构位列买入2.05亿,卖出3235万,净买入1.72亿,上榜席位买入2.29亿,卖出7742万,合计净买入1.52亿
Ge Long Hui· 2025-07-31 09:08
| 买入金额最大的前5名 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 序号 | 交易营业部名称 | | | 买入金额(万) | 占总成交比例 | 卖出金额(万) | 占总成交比例 | 净额(万)® | | 1 | 机构专用 | 1414次 43.42% | 0 | 8269.79 | 7.10% | 0.00 | 0.00% | 8269 79 | | 2 | 机构专用 | 1414次 43 42% | ▶ | 3797.68 | 3.26% | 126.59 | 0.11% | 3671.09 | | 3 | 机构专用 | 1414次 43.42% | A | 3490.92 | 3.00% | 1960.58 | 1.68% | 1530.34 | | 4 | 机构专用 | 1414次 43.42% | | 2990.94 | 2.57% | 0.00 | 0.00% | 2990.94 | | 5 | 机构专用 | 1414次 43.42% | ▶ | 1913.61 | 1.64% | 0.00 ...
龙虎榜 | 昂利康今日涨停,5家机构专用席位净买入1.84亿元
Xin Lang Cai Jing· 2025-07-31 09:07
(文章来源:智通财经) 昂利康今日涨停,成交额11.65亿元,换手率11.32%,盘后龙虎榜数据显示,5家机构专用席位净买入 1.84亿元,有1家机构专用席位净卖出1147.94万元。 ...
昂利康:西格列汀二甲双胍缓释片完成药品注册
Zhi Tong Cai Jing· 2025-07-31 09:05
Core Viewpoint - The company, Anglikang (002940.SZ), has received a drug registration certificate from the National Medical Products Administration for its product, Sitagliptin Metformin Extended-Release Tablets, indicating a significant regulatory milestone for the company in the diabetes treatment market [1] Group 1 - The Sitagliptin Metformin Extended-Release Tablets are a compound formulation designed for adult patients with type 2 diabetes who are currently undergoing treatment with both Sitagliptin and Metformin Extended-Release Tablets [1]
昂利康:获得西格列汀二甲双胍缓释片药品注册证书
Xin Lang Cai Jing· 2025-07-31 09:04
Core Viewpoint - The company has received the drug registration certificate for the combination drug Sitagliptin Metformin Extended-Release Tablets from the National Medical Products Administration, which is intended for adult patients with type 2 diabetes currently undergoing treatment with both Sitagliptin and Metformin Extended-Release Tablets [1] Group 1 - The drug is a compound formulation suitable for adult patients with type 2 diabetes [1] - The company received the drug marketing license application acceptance notice in January 2024 and has recently obtained approval from the National Medical Products Administration [1] - The approval of the drug registration certificate is considered equivalent to passing the consistency evaluation, which will further enrich the company's product pipeline [1] Group 2 - There is significant uncertainty regarding the specific sales performance of the newly approved drug [1]
昂利康(002940.SZ):西格列汀二甲双胍缓释片获得药品注册证书
Ge Long Hui A P P· 2025-07-31 09:04
格隆汇7月31日丨昂利康(002940.SZ)公布,近日,浙江昂利康制药股份有限公司收到国家药品监督管理 局签发的西格列汀二甲双胍缓释片《药品注册证书》。西格列汀二甲双胍缓释片为复方制剂,适用于正 在接受西格列汀和二甲双胍缓释片联合治疗的成人2型糖尿病患者。 ...
昂利康(002940) - 关于获得药品注册证书的公告
2025-07-31 09:00
证券代码:002940 证券简称:昂利康 公告编号:2025-056 浙江昂利康制药股份有限公司 关于获得药品注册证书的公告 三、对公司的影响 本次西格列汀二甲双胍缓释片获得药品注册证书,将进一步丰富公司产品管 线。由于医药行业的特殊性,药品的销售容易受到国家政策、市场环境变化等因 素影响,具体销售情况存在较大不确定性。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 近日,浙江昂利康制药股份有限公司(以下简称"公司")收到国家药品监 督管理局(以下简称"国家药监局")签发的西格列汀二甲双胍缓释片《药品注 册证书》,现将有关情况公告如下: | 药品通用名称 | 西格列汀二甲双胍缓释片 | | --- | --- | | 主要成份 | 磷酸西格列汀和盐酸二甲双胍 | | 剂型 | 片剂 | | 申请事项 | 药品注册(境内生产) | | 注册分类 | 化学药品 3 类 | | 规格 | 磷酸西格列汀 50mg(按 C₁₆H₁₅F₆N₅O 计)与盐酸二甲 | | | 双胍 500mg | | 受理号 | CYHS2400188、CYHB2500250 | | 药品 ...
龙虎榜丨昂利康涨停,六机构净买入1.72亿元
Ge Long Hui A P P· 2025-07-31 08:37
| | 买入金额最大的前5名 | | | | | | --- | --- | --- | --- | --- | --- | | 序号 | | 交易营业部名称 | | 买入金额(万) | 占总成交比例 | | 1 | 机构专用 | | 1414次 43.42% 2 | 8269.79 | 7.10% | | 2 | 机构专用 | Castmoney.com | 1414次 43.42% b | 3797.68 | 3.26% | | 3 | 机构专用 | | 1414次 43.42% | 3490.92 | 3.00% | | 4 | 机构专用 | | 1414次 43.42% | 2990.94 | 2.57% | | 5 | 机构专用 | | 1414次 43.42% | 1913.61 | 1.64% | | | 卖出金额最大的前5名 | | | | | | 序号 | 交易营业部名称 | | 买入金额(万) | 占总成交比例 | | --- | --- | --- | --- | --- | | 1 | 机构专用 | 1414次 43.42% 2 | 3490.92 | 3.00% | | 2 | 中信 ...
昂利康今日涨10.00% 5家机构专用席位净买入1.84亿元
Xin Lang Cai Jing· 2025-07-31 08:29
昂利康今日涨10.00%,成交额11.65亿元,换手率11.32%,盘后龙虎榜数据显示,5家机构专用席位净买 入1.84亿元,有1家机构专用席位净卖出1147.94万元。 ...
51只股涨停 最大封单资金4.61亿元
截至收盘,上证指数报收3573.21点,下跌1.18%;深证成指收于11009.77点,下跌1.73%;创业板指下 跌1.66%;科创50指数下跌1.01%。 | 002940 | 昂利康 | 57.20 | 11.32 | 67.85 | 3880.99 | 医药生物 | | --- | --- | --- | --- | --- | --- | --- | | 600828 | 茂业商业 | 4.66 | 5.07 | 813.93 | 3792.90 | 商贸零售 | | 600774 | 汉商集团 | 11.33 | 8.01 | 322.68 | 3655.95 | 医药生物 | | 002799 | 环球印务 | 9.24 | 9.38 | 352.96 | 3261.36 | 轻工制造 | | 603516 | 淳中科技 | 60.48 | 11.90 | 52.57 | 3179.43 | 计算机 | | 001318 | 阳光乳业 | 18.14 | 18.45 | 158.69 | 2878.64 | 食品饮料 | | 603273 | 天元智能 | 21.09 | 38.88 | 122 ...